SCHEMBL22497616

SCHEMBL22497616

C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 1.00
ALK Q9UM73 6/20 1.00
EML4 Q9HC35 5/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22497626 0.88 EGFR (0.85) EGFRALKEML4
SCHEMBL22520213 0.88 EGFR (1.00) EGFRALKEML4
SCHEMBL22497656 0.88 EGFR (1.00) EGFRALKEML4
SCHEMBL19089663 0.88 EGFR (0.82) EGFRALKEML4
SCHEMBL19337095 0.87 EGFR (0.77) EGFRALKEML4
SCHEMBL19337136 0.87 EGFR (0.77) EGFRALKEML4
SCHEMBL22497633 0.87 EGFR (0.77) EGFRALKEML4
SCHEMBL19337177 0.87 EGFR (0.76) EGFRALKEML4
SCHEMBL19337163 0.87 EGFR (0.76) EGFRALKEML4
SCHEMBL27237904 0.87 EGFR (0.80) EGFRALKEML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed